Author

Bülent Çetin

Observed names: B. Cetin, Bulent Cetin, Bülent Cetin, Bülent ÇETİN, Çetin, Bülent

Observed institutions: Sivas Cumhuriyet Üniversitesi, Ministry of Health, Recep Tayyip Erdoğan University, Queen Mary University of London, Süleyman Demirel Üniversitesi, Research Institute of Molecular Pathology, Ondokuz Mayıs University, University of California San Diego, University of Oxford, Suleyman Demirel University Research and Education Hospital, Sağlık Bilimleri Üniversitesi, Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi, Ludwig Cancer Research, Gazi University

ORCID: 0000-0001-8628-0864

Observed ORCID: 0000-0001-8628-0864

OpenAlex ID: A5064627647

Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I

2006 · Christian G. Riedel, Vittorio L. Katis, et al. · Nature · 460

Structure and Function of the PP2A-Shugoshin Interaction

2009 · Zheng Xu, Bulent Cetin, et al. · Molecular Cell · 200

PDF

Catalytic Assembly of the Mitotic Checkpoint Inhibitor BubR1-Cdc20 by a Mad2-Induced Functional Switch in Cdc20

2013 · Joo Seok Han, Andrew J. Holland, et al. · Molecular Cell · 105

PDF

Pembrolizumab for Early Triple-Negative Breast Cancer

2020 · Bulent Cetin, Ozge Gumusay · New England Journal of Medicine · 90

Sonographic assessment of fatty liver: intraobserver and interobserver variability.

2014 · Mustafa Cengiz, Senem Sentürk, et al. · PubMed · 72

Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?

2012 · Bulent Cetin, Veli Berk, et al. · Clinical Genitourinary Cancer · 50

Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)

2013 · Bulent Cetin, Mustafa Benekli, et al. · Journal of Chemotherapy · 36

Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme

2018 · Bulent Cetin, Ipek Isık Gonul, et al. · Neuropathology · 33

Prognostic value of claudin 18.2 expression in gastric adenocarcinoma

2023 · Erkan Kayikcioglu, Ramazan Oğuz Yüceer, et al. · World Journal of Gastrointestinal Oncology · 29

Prognostic Factors for Overall Survival in Patients With Metastatic Colorectal Carcinoma Treated With Vascular Endothelial Growth Factor-Targeting Agents

2012 · Bulent Cetin, Mehmet Ali Kaplan, et al. · Asian Pacific Journal of Cancer Prevention · 29

PDF

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

2023 · Seda Kahraman, Enes Erul, et al. · Future Oncology · 27

GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas

2017 · A. Cakir, I. Isik Gonul, et al. · Pathology - Research and Practice · 27

CDK4/6 Inhibitors: Mechanisms of Resistance and Potential Biomarkers of Responsiveness in Breast Cancer

2022 · Bulent Cetin, Chiara A Wabl, et al. · Future Oncology · 25

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 24

PDF

Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience

2013 · Bulent Cetin, Mustafa Benekli, et al. · Breast Care · 24

PDF

Advances of Molecular Targeted Therapy in Gastric Cancer

2016 · Bulent Cetin, Ozge Gumusay, et al. · Journal of Gastrointestinal Cancer · 22

Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

2013 · Ozge Gumusay, Ugur Coskun, et al. · Journal of Cancer Research and Clinical Oncology · 22

Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma

2013 · Bulent Cetin, Barıs Afsar, et al. · International Urology and Nephrology · 21

Results of Adjuvant FOLFOX Regimens in Stage III Colorectal Cancer Patients: Retrospective Analysis of 667 Patients

2013 · Doğan Uncu, Sercan Aksoy, et al. · Oncology · 21

Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

2012 · Bulent Cetin, Mustafa Benekli, et al. · Onkologie · 20

PDF

The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N0 head and neck cancers

2013 · Bulent Cetin, Tamer Atasever, et al. · European Archives of Oto-Rhino-Laryngology · 18

Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor

2012 · B. Cetin, M. A. Kaplan, et al. · Japanese Journal of Clinical Oncology · 17

Sunitinib- and Sorafenib-lnduced Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor

2012 · Nedim Turan, Mustafa Benekli, et al. · Annals of Pharmacotherapy · 17

Isolated Primary Lymphomatoid Granulomatosis of Central Nervous System

2011 · Bulent Cetin, Mustafa Benekli, et al. · Indian Journal of Hematology and Blood Transfusion · 16

PDF

Kaposi’s sarcoma in patients with ulcerative colitis receiving immunosuppressive drugs: Report of a case

2011 · Bülent ÇETİN, Süleyman BÜYÜKBERBER, et al. · The Turkish Journal of Gastroenterology · 15

PDF

Works count: 108

Citation count: 1,702

H-index: 20

I10-index: 32